Cooley’s 2019 Life Sciences M&A Year in Review – Cooley M&A
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of...
Cooley’s 2019 Tech M&A Year in Review – Cooley M&A
In the wake of record-setting volume and value metrics in 2018, practitioners eyed the...
Salladay v. Lev Clarifies Committee Formation Requirements in Non-MFW Scenarios – Cooley M&A
In late February as the COVID-19 pandemic was accelerating, the Delaware Chancery Court issued...
10 Key Considerations for Going Public with a SPAC – Cooley M&A
It is a reasonable extrapolation – and we are nothing at Cooley if not...
Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties – Cooley M&A
In Captain Phillips, a pirate hijacks a ship and turns to the captain and...
DOJ Issues Merger Remedies Manual as Both DOJ and FTC Step Up Efforts to Enforce Consent Decrees – Cooley M&A
The U.S. Department of Justice (DOJ) Antitrust Division issued a new Merger Remedies Manual...
Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs! – Cooley M&A
On September 24, Cooley M&A partner, Garth Osterman, moderated a webinar on the current...
Cooley’s 2020 Tech M&A Year in Review – Cooley M&A
A Tale of Two Years While we continue to absorb and understand the worldwide...
SPAC Trend Gives Rise to Securities Enforcement and Litigation Risks – Cooley M&A
What is a SPAC Special purpose acquisition companies (SPACs) are on the rise. A...
Invoking Prevention Doctrine, Delaware Chancery Court Grants Seller’s Request for Specific Performance in COVID-Related M&A Dispute – Cooley M&A
Chancellor McCormick’s opinion in Snow Phipps Group, LLC, et al. v. KCake Acquisition, Inc.,...